Edition:
United Kingdom

Viveve Medical Inc (VIVE.OQ)

VIVE.OQ on NASDAQ Stock Exchange Capital Market

3.17USD
19 Apr 2018
Change (% chg)

$-0.12 (-3.65%)
Prev Close
$3.29
Open
$3.31
Day's High
$3.35
Day's Low
$3.15
Volume
58,199
Avg. Vol
63,023
52-wk High
$8.66
52-wk Low
$2.96

Chart for

About

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a... (more)

Overall

Beta: -0.62
Market Cap(Mil.): $108.86
Shares Outstanding(Mil.): 19.41
Dividend: --
Yield (%): --

Financials

  VIVE.OQ Industry Sector
P/E (TTM): -- 148.40 32.74
EPS (TTM): -2.12 -- --
ROI: -103.95 9.37 14.38
ROE: -217.66 14.69 16.07

BRIEF-Viveve Announces Pricing Of Public Offering Of Shares

* VIVEVE ANNOUNCES PRICING OF PUBLIC OFFERING OF SHARES OF COMMON STOCK

08 Feb 2018

BRIEF-Viveve Announces Proposed Public Offering Of Shares Of Common Stock

* VIVEVE ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK

07 Feb 2018

BRIEF-Viveve Announces Preliminary 2017 Fourth Quarter Results

* VIVEVE ANNOUNCES PRELIMINARY 2017 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS AND PROVIDES 2018 REVENUE GUIDANCE

04 Jan 2018

BRIEF-Viveve Medical Inc files for mixed shelf of up to $50 million

* Viveve Medical Inc files for mixed shelf of up to $50 million Source text: (http://bit.ly/2zIf6EQ) Further company coverage:

08 Nov 2017

BRIEF-Viveve reports Q3 loss per share $0.50

* Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S

08 Nov 2017

Earnings vs. Estimates